|
|
Chronic Pain Modulation of Mesolimbic Dopamine Signaling for Natural and Opiate Rewards |
| 1F31DA056200-01 |
|
NIDA |
2022 |
|
|
Neurocognitive Impairments Resulting from Adolescent Prescription Opioid Use Disorder: Longitudinal Impact, Neural Mechanisms, and Comorbidities |
| 1K99DA056288-01 |
|
NIDA |
2022 |
|
|
Role of disability and pain in opioid overdose: mechanism and risk mitigation |
| 1R01DA053243-01A1 |
|
NIDA |
2022 |
|
|
A pilot study of ambulatory Heart Rate Variability Biofeedback for substance use disorder |
| 1R21DA056468-01 |
|
NIDA |
2022 |
|
|
Deep Brain Stimulation (DBS) For Severe Treatment Refractory Methamphetamine Use Disorder |
| 1UG3DA054746-01A1 |
|
NIDA |
2022 |
|
|
Effect of buprenorphine on monocytes in the context of neuroAids and opioid abuse |
| 2R01DA041931-07A1 |
|
NIDA |
2022 |
|
|
Wearable sensor for opioids detection based on electrochemical sensor arrayintegrated with Bluetooth device |
| 2R44DA051289-02 |
|
NIDA |
2022 |
|
|
Neural circuitry mediating behavioral flexibility |
| 3R00DA042934-05S2 |
|
NIDA |
2022 |
|
|
Systems biology of RNA Modifications in HIV/AIDS and Substance Use Disorders |
| 3R01DA046170-05S1 |
|
NIDA |
2022 |
|
|
Methamphetamine Effects on Prefrontal Cortical PV+ Interneurons and Resulting Cognitive Deficits |
| 3R01DA054589-02S1 |
|
NIDA |
2022 |
